Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSITE D'AIX-MARSEILLE has 4 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed across 4 distinct examiners and 4 distinct art units, giving each action a separate examiner and technical setting.
ROSWELL, JESSICA MARIE is the busiest examiner, with 1 pending action. The data supports independent matter-level preparation rather than a shared examiner response strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 2 (50%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROSWELL, JESSICA MARIE | 1 | 52.1% | +36.4% |
| DRISCOLL, LORA E BARNHART | 1 | 31.8% | +20.8% |
| TAYLOR, LIA ELAN | 1 | 64.2% | +29.5% |
| HAM, JIEUN | 1 | 45.5% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719893 | A LIGHT-ACTIVATED RESIN COMPOSITION AND ITS USE IN 3D-PRINTING | ROSWELL, JESSICA MARIE | — |
| 17913416 | APHERESIS COLUMN FOR TREATING RHEUMATOID ARTHRITIS | HAM, JIEUN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18355451 | TAFA4 Compounds and Uses Thereof for Treating Pain | DRISCOLL, LORA E BARNHART | 27d |
| 18719893 | A LIGHT-ACTIVATED RESIN COMPOSITION AND ITS USE IN 3D-PRINTING | ROSWELL, JESSICA MARIE | — |
| 18339781 | TRANSFERRIN RECEPTOR-BINDING MOLECULES, CONJUGATES THEREOF AND THEIR USES | TAYLOR, LIA ELAN | — |
| Art Unit | Apps |
|---|---|
| 1767 | 1 |
| 3991 | 1 |
| 1641 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18719893 | A LIGHT-ACTIVATED RESIN COMPOSITION AND ITS USE IN 3D-PRINTING | ROSWELL, JESSICA MARIE | 1767 | §102§103 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18355451 | TAFA4 Compounds and Uses Thereof for Treating Pain | DRISCOLL, LORA E BARNHART | 3991 | §112Other | Final Rejection | 27d | Pending | Jul 20, 2023 |
| 18339781 | TRANSFERRIN RECEPTOR-BINDING MOLECULES, CONJUGATES THEREOF AND THEIR USES | TAYLOR, LIA ELAN | 1641 | §112Other | Final Rejection | — | Pending | Jun 22, 2023 |
| 17913416 | APHERESIS COLUMN FOR TREATING RHEUMATOID ARTHRITIS | HAM, JIEUN | 1643 | §102§103§112Other | Final Rejection | — | Pending | Sep 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITE D'AIX-MARSEILLE has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Jessica Marie Roswell has the most, with 1 of UNIVERSITE D'AIX-MARSEILLE's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
